Starpharma (ASX:SPL) share price jumps 7% on COVID variant update

This healthcare company is helping to fight the spread of COVID-19…

| More on:
covid asx share price represented by man in face mask giving thumbs up

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Starpharma Holdings Limited (ASX: SPL) share price is on course to end the week on a strong note.

At the time of writing, the dendrimer products developer's shares are up 7% to $1.66.

Why is the Starpharma share price pushing higher?

The Starpharma share price is pushing higher today after the company released another update on its COVID-fighting Viraleze antiviral nasal spray.

According to the release, new data demonstrates that the active ingredient in the Viraleze antiviral nasal spray, SPL7013, has been shown to be highly effective against various COVID-19 strains.

The release explains that SPL7013 achieved a more than 99.9% reduction of virus against the Alpha (UK), Beta (South Africa) and Gamma (Japan/Brazil) SARS-CoV-2 coronavirus variants of concern in laboratory-based virucidal assays. The testing of SPL7013 was conducted in the laboratory of virologist Professor Philippe Gallay at The Scripps Research Institute in the United States.

Management advised that SPL7013 virucidal activity against the Alpha, Beta and Gamma variants in the current assays were broadly consistent with the virucidal activity demonstrated in the US strain of SARS-CoV2 in the same assay.

It notes that within 30 seconds to 1 minute of exposure, SPL7013 achieved >99% reduction in infectious virus against Beta and Gamma variants, and >99.9% within 5 minutes. The Alpha variant was quicker, achieving a >99.9% reduction in infectious virus within 30 seconds to 1 minute of exposure.

Starpharma's CEO, Dr Jackie Fairley, commented: "We are very pleased to see such potent and rapid virucidal activity of Viraleze against multiple SARS-CoV-2 variants of concern, Alpha, Beta, and Gamma. These variants continue to spread across the globe and challenge efforts to control the COVID-19 pandemic."

"Given its broad spectrum of activity, Viraleze could prove to be particularly beneficial as an additional protective measure against these variants. This could prove particularly useful in settings where these variants can be problematic, like hotel quarantine and major international events such as the Tokyo Olympics," she concluded.

James Mickleboro does not own any shares mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Starpharma Holdings Limited. The Motley Fool Australia has recommended Starpharma Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »